ARDS患者ECMO期间机械通气管理:国际多中心前瞻性队列研究
该国际多中心前瞻性队列研究纳入23个ICU中350例因重症ARDS接受ECMO的患者,报告ECMO期间机械通气实践及与6个月结局的关联。ECMO启动后潮气量、平台压、驱动压、呼吸频率及机械功均明显降低,6个月生存率61%;ECMO前2天通气参数与生存无关,而年龄、液体平衡、乳酸及肾脏替代治疗需求与6个月死亡率独立相关。
要点
- ECMO启动后普遍采用超保护性肺通气,潮气量、平台压及驱动压明显降低。
- ECMO前2天通气参数与6个月生存无独立关联。
- 年龄、液体正平衡、高乳酸及肾脏替代治疗需求与6个月死亡率独立相关。
核心结论
- 在中等至高病例量的ECMO中心,ARDS患者ECMO期间普遍采用超保护性肺通气。
- ECMO期间机械通气参数未影响患者预后,与既往观察不同。
研究设计与样本
- 国际、多中心、前瞻性队列研究,纳入23个国际ICU在1年期间因ARDS接受ECMO的患者。
- 共纳入350例患者,ECMO前PaO2/FiO2均值±SD为71±34 mm Hg。
主要发现
- ECMO启动后潮气量由6.4±2.0降至3.7±2.0 ml/kg,平台压由32±7降至24±7 cm H2O。
- 驱动压由20±7降至14±4 cm H2O,呼吸频率由26±8降至14±6次/分,机械功由26.1±12.7降至6.6±4.8 J/min。
- ECMO前俯卧位通气使用率26%,神经肌肉阻滞剂使用率62%。
- 6个月生存率为61%。
- 多变量分析未发现ECMO前2天通气参数与生存的关联;时变Cox模型显示年龄较大、液体平衡较高、乳酸较高及ECMO期间肾脏替代治疗需求较多与6个月死亡率独立相关。
关键数值与推荐
- ECMO期间较高潮气量和较低驱动压(可能为静态顺应性改善的标志)与更好结局相关。
临床怎么用
- 在ECMO中心对重症ARDS患者可采用超保护性肺通气策略。
- ECMO期间应关注液体平衡、乳酸水平及肾脏替代治疗需求等预后相关因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Current practices regarding mechanical ventilation in patients treated with extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome are unknown.Objectives: To report current practices regarding mechanical ventilation in patients treated with ECMO for severe acute respiratory distress syndrome (ARDS) and their association with 6-month outcomes.Methods: This was an international, multicenter, prospective cohort study of patients undergoing ECMO for ARDS during a 1-year period in 23 international ICUs.Measurements and Main Results: We collected demographics, daily pre- and per-ECMO mechanical ventilation settings and use of adjunctive therapies, ICU, and 6-month outcome data for 350 patients (mean ± SD pre-ECMO PaO2/FiO2 71 ± 34 mm Hg). Pre-ECMO use of prone positioning and neuromuscular blockers were 26% and 62%, respectively. Vt (6.4 ± 2.0 vs. 3.7 ± 2.0 ml/kg), plateau pressure (32 ± 7 vs. 24 ± 7 cm H2O), driving pressure (20 ± 7 vs. 14 ± 4 cm H2O), respiratory rate (26 ± 8 vs. 14 ± 6 breaths/min), and mechanical power (26.1 ± 12.7 vs. 6.6 ± 4.8 J/min) were markedly reduced after ECMO initiation. Six-month survival was 61%. No association was found between ventilator settings during the first 2 days of ECMO and survival in multivariable analysis. A time-varying Cox model retained older age, higher fluid balance, higher lactate, and more need for renal-replacement therapy along the ECMO course as being independently associated with 6-month mortality. A higher Vt and lower driving pressure (likely markers of static compliance improvement) across the ECMO course were also associated with better outcomes.Conclusions: Ultraprotective lung ventilation on ECMO was largely adopted across medium- to high-case volume ECMO centers. In contrast with previous observations, mechanical ventilation settings during ECMO did not impact patients' prognosis in this context.
引用
- Schmidt M, Pham T, Arcadipane A, et al. Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort. Am J Respir Crit Care Med. 2019. PMID: 31144997. doi:10.1164/rccm.201806-1094OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。